And while we observe some anti-cancer effects of PLK1is as single agents in MYC-non-amplified background, it is less significant compared to MYC-amplified cells, possibly due to moderate expression of and dependence on of MYC and/or PLK1. The gene discussed is PLK1; the disease is cancer.